Company Filing History:
Years Active: 2016
Title: Innovations in Parkinson's Disease Treatment by Anne Michel
Introduction
Anne Michel is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. Her innovative approach combines the use of specific pharmaceutical agents to enhance therapeutic outcomes for patients suffering from this debilitating condition.
Latest Patents
Anne Michel holds a patent for her invention titled "Methods for treating Parkinson's disease." This patent describes a method of treating Parkinson's disease in mammals by administering a first pharmaceutical agent, which is an antagonist of the adenosine receptor 2 (A), alongside a second pharmaceutical agent that acts as an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B. This dual approach aims to improve the efficacy of treatment for patients.
Career Highlights
Throughout her career, Anne has demonstrated a strong commitment to advancing medical science. Her work at UCB Biopharma Sprl has positioned her as a key player in the pharmaceutical industry. With her innovative mindset, she continues to explore new avenues for improving patient care and treatment methodologies.
Collaborations
Anne collaborates with notable colleagues such as Patrick Downey and Florian Montel. Their combined expertise fosters a dynamic environment for research and development, leading to groundbreaking advancements in the treatment of neurological disorders.
Conclusion
Anne Michel's contributions to the treatment of Parkinson's disease exemplify the impact of innovation in medicine. Her patented methods represent a significant step forward in enhancing the quality of life for patients.